查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
基因板市场 - 2018-2028F全球行业规模、份额、趋势、机会和预测，按组件、技术、设计、应用、终端用户、区域和竞争情况分类
市场调查报告书
商品编码
1303129

基因板市场 - 2018-2028F全球行业规模、份额、趋势、机会和预测，按组件、技术、设计、应用、终端用户、区域和竞争情况分类

Gene Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Component, By Technique, By Design, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在预测期内，全球基因板市场预计将见证令人印象深刻的增长。这可以归因于唐氏综合症、镰状细胞病、留守儿童病等遗传性疾病的日益流行。由于人们保健意识的提高和对早期诊断需求的增加，许多夫妇在计划生育前或怀孕期间选择基因检测，进一步推动了预测期内的市场。由于技术的低成本和快速准确的测试，基因板的应用越来越多，预计将推动市场增长。此外，不断改善的医疗基础设施，加上对基因板相关研究和开发的投资不断增加，预计在未来几年将进一步为市场增长创造有利可图的机会。

慢性疾病的发病率不断增加

癌症、先天性疾病、心脏病和关节炎等慢性疾病的发病率不断上升，预计在预测期内，基因板市场会有所增长。由于基因突变导致的疾病越来越多，需要进行基因小组测试。它是一种诊断技术，同时分析许多与癌症相关的基因改变。主要的关键参与者开发和推出癌症疗法对基因板的高需求，预计将在预测期内促进基因板市场的增长。根据全球癌症观察站的数据，全世界大约有19,292,789个新的癌症病例。其中，9,227,484个新的癌症病例是在女性中报告的，而男性新的癌症病例数量约为10,065,305个。癌症发病率的增长将增加对基因小组的需求。鉴于成本高昂，基因检测通常只对那些因遗传性疾病而患特定类型癌症的高风险患者进行。这可能包括生活方式的因素，如吸烟、过不健康的生活方式、减少体育活动和饮酒。根据世界卫生组织（WHO）的数据，全世界每年约有295 000名新生儿在出生后28天内因先天性畸形而死亡。

技术进步

对先进医疗检测的需求不断增加，加上临床诊断中的个性化药物，将在预测期内为市场增长创造有利可图的机会。目前，遗传性疾病在老年人群中很常见，这为基因板市场的增长提供了广泛的支持。许多全球公司正专注于开发新的和先进的基因小组，这将进一步推动未来几年的市场增长。许多私人和政府组织对开发新技术的倡议和投资不断增加，这是推动市场增长的一个主要因素。每年在美国出生的每33个婴儿中就有一个受到出生缺陷的影响，这意味着大约有12万个婴儿。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需要提供定制服务。该报告可提供以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

  • 市场定义
  • 市场的范围
    • 涵盖的市场
    • 研究考虑的年份
    • 关键的市场细分

第二章：研究方法

  • 研究的目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二级来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第三章：执行摘要

  • 市场概述
  • 主要市场细分概述
  • 主要市场参与者概述
  • 主要地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第四章：客户的声音

第五章：全球基因板市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按成分（检测试剂盒和检测服务）分类
    • 按技术分类（基于扩增子的方法 v/ 基于杂交的方法）
    • 按设计（预先设计的基因组 v/ 定制的基因组）
    • 按应用（癌症风险评估、先天性疾病的诊断、药物遗传学、其他）
    • 按终端用户（学术和研究机构、医院和诊断实验室、制药和生物技术公司）分类
    • 按地区分类
    • 按公司分类(2022年)
  • 市场地图
    • 按组件分类
    • 按技术分类
    • 按设计分类
    • 按应用分类
    • 按终端用户分类
    • 按地区分类

第6章：北美基因小组市场前景

  • 市场规模和预测
    • 按价值分类
  • 市场份额与预测
    • 按成分分类
    • 按技术分类
    • 按设计分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第七章：欧洲基因小组市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按成分分类
    • 按技术分类
    • 按设计分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第8章：亚太地区基因小组市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按成分分类
    • 按技术分类
    • 按设计分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第九章：南美基因小组市场展望

  • 市场规模和预测
    • 按价值计算
  • 市场份额和预测
    • 按成分分类
    • 按技术分类
    • 按设计分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东和非洲的基因小组市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额和预测
    • 按成分分类
    • 按技术分类
    • 按设计分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类
  • MEA: 国家分析
    • 南非基因小组
    • 沙特阿拉伯基因小组
    • 阿拉伯联合酋长国基因小组

第11章 ：市场动态

  • 驱动力
  • 挑战

第十二章 ：市场趋势与发展

  • 最近的发展情况
  • 合併和收购
  • 产品发布

第十三章 ：竞争格局

  • 业务概况 产品供应 近期发展 财务状况（如报告所示） 主要人员 SWOT分析
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fischer Scientific, Inc.
    • QIAGEN NV
    • Eurofins Scientific SE
    • Foundation Medicine Inc.
    • Guardant Health, Inc.
    • Myriad Genetic Laboratories Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG

第十四章：战略建议

简介目录
Product Code: 14590

Global gene panel market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of genetic disorders like Down syndrome, sickle cell disease, stay-Sachs disease, and others. Due to increasing healthcare awareness among the population and rising demand for early diagnosis, lots of couples opt for genetic testing before baby planning or during pregnancy, further boosting the market over the forecast period. Increasing application of gene panels owing to the low cost of the technique and fast and accurate testing is expected to propel market growth. Besides, improving healthcare infrastructure coupled with growing investments in research & development related to gene panels is further expected to create lucrative opportunities for market growth in the coming years.

Growing Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, congenital diseases, heart attack, and arthritis is expected to grow in the gene panel market during the forecast period. Increasing disorders because of genetic mutation demand gene panel testing. It is a diagnostic technique that analyses many genes for cancer-associated alterations at the same time. High demand for gene panels by the major key players to develop and launch cancer therapy is expected to growth of the gene panel market over the forecast period. According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide. Out of these, 9,227,484 new cancer cases were reported in females, while the number of new cancer cases reported in men was around 10,065,305. The growing prevalence of cancer will increase the demand for gene panels. Given the high cost, genetic testing is usually only carried out on patients who are at a high risk of developing specific types of cancer because of their heredity disorder. This may include lifestyle factors such as smoking, leading an unhealthy lifestyle, reduced physical activity, and alcohol consumption. According to World Health Organization (WHO), around 295 000 newborns die within 28 days of birth every year worldwide due to congenital anomalies.

Technological Advancements

Increasing demand for advanced medical testing, along with personalized medicines in clinical diagnosis, will create lucrative opportunities for market growth in the forecast period. Currently, genetic disorders are common in the geriatric population, which supports the gene panel market growth extensively. Many global companies are focusing on developing new and advanced gene panels, which is further expected to propel market growth over the coming years. Increasing initiative and investment by many private and government organizations for developing new technology is a major factor that boosts market growth. Birth defects affect 1 in every 33 babies born in the United States each year, which translates into about 120,000 babies.

Market Segmentation

The global gene panel market can be segmented by component, technique, design, application, end-user, and by region. Based on components, the market can be divided into Test Kits and Testing Services. Based on technique, the market can be divided into Amplicon Based Approach and Hybridization Based Approach. Based on the design, the market can be divided into Predesigned Gene Panels and Customized Gene Panels. Based on Application, the market can be segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, and Others. Based on end-user, the market can be differentiated into Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the Global Gene Panel Market on account of the growing demand for gene panel techniques for rising cases of cancer across the globe. A little over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022, according to the 2022 Cancer Facts & Figures report from the American Cancer Society (ACS).

Market Players

Illumina, Inc., Agilent Technologies, Inc., Thermo Fischer Scientific, Inc., QIAGEN NV, Eurofins Scientific SE, Foundation Medicine Inc., Guardant Health, Inc., Myriad Genetic Laboratories Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG are some of the leading players operating in the Global Gene Panel Market.

Report Scope

In this report, global gene panel market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Gene Panel Market, By Component:

  • Test Kits
  • Testing Services

Gene Panel Market, By Technique:

  • Amplicon Based Approach
  • Hybridization Based Approach

Gene Panel Market, By Design:

  • Predesigned Gene Panel
  • Customized Gene Panel

Gene Panel Market, By Application:

  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others

Gene Panel Market, By End User:

  • Academic & Research Institutes
  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies

Gene Panel Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Gene Panel Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Panel Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Test Kits v/s Testing Services)
    • 5.2.2. By Technique (Amplicon Based Approach v/s Hybridization Based Approach)
    • 5.2.3. By Design (Predesigned Gene Panel v/s Customized Gene Panel)
    • 5.2.4. By Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others)
    • 5.2.5. By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technique
    • 5.3.3. By Design
    • 5.3.4. By Application
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Gene Panel Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technique
    • 6.2.3. By Design
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gene Panel Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Design
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Gene Panel Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Design
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Gene Panel Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Design
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Gene Panel Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technique
    • 7.2.3. By Design
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Gene Panel Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Design
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Gene Panel Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Design
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Gene Panel Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Design
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Gene Panel Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Design
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Gene Panel Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Design
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Gene Panel Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technique
    • 8.2.3. By Design
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Gene Panel Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Design
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Gene Panel Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Design
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Gene Panel Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Design
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Gene Panel Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Design
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Gene Panel Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Design
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Gene Panel Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technique
    • 9.2.3. By Design
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Gene Panel Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Design
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Gene Panel Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Design
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Gene Panel Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Design
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Gene Panel Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technique
    • 10.2.3. By Design
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Gene Panel Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Design
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Gene Panel Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Design
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Gene Panel Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Design
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Illumina, Inc.
    • 13.6.2. Agilent Technologies, Inc.
    • 13.6.3. Thermo Fischer Scientific, Inc.
    • 13.6.4. QIAGEN NV
    • 13.6.5. Eurofins Scientific SE
    • 13.6.6. Foundation Medicine Inc.
    • 13.6.7. Guardant Health, Inc.
    • 13.6.8. Myriad Genetic Laboratories Inc.
    • 13.6.9. Bio-Rad Laboratories, Inc.
    • 13.6.10. F. Hoffmann-La Roche AG

14. Strategic Recommendations